TECTONIC THERAPEUTIC INC (TECX) Stock Analyst Earnings Estimates
NASDAQ:TECX - Nasdaq - US8789721086 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||||
| EBITDA YoY % growth | N/A | N/A -70.63% | N/A -79.81% | -15.246M 88.25% | -31.824M -108.74% | -124.09M -289.93% | -56.37M 54.57% | N/A -42.95% | N/A -12.66% | N/A -17.98% | N/A | |
| EBIT YoY % growth | N/A | N/A -69.45% | N/A -74.68% | -15.61M 87.81% | -32.83M -110.31% | -125.568M -282.48% | -58.015M 53.80% | N/A -41.33% | N/A -24.06% | N/A -37.05% | N/A 99.12% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | -2.68 93.05% | -3.31 -23.51% | -2.79 15.71% | -2.41 13.62% | -3.78 -56.85% | -8.18 -116.40% | N/A 49.17% | N/A -13.29% | N/A -25.44% | N/A |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.00 76.93% | -1.04 13.02% | -1.09 -29.62% | -1.35 -45.14% | -1.40 -39.56% | -1.41 -34.85% | -1.43 -31.15% |
| Revenue Q2Q % growth | |||||||
| EBITDA Q2Q % growth | -20.4M -90.51% | -20.4M -10.27% | -21.42M -73.50% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -19.997M -75.09% | -20.834M -6.09% | -21.245M -51.85% | -25.867M -41.36% | -21.363M -6.83% | -21.742M -4.36% | -22.129M -4.16% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -0.93 48.33% | -1.11 | 0.18 | 16.54% |
| Q4 2024 Q2Q % growth | -0.84 65.00% | -1.41 | 0.57 | 40.61% |
| Q3 2024 Q2Q % growth | -1.20 -172.73% | -0.84 | -0.36 | -42.60% |
| Q2 2024 Q2Q % growth | -4.34 -1,072.97% | -1.53 | -2.81 | -183.66% |
| Q1 2024 Q2Q % growth | -1.80 -215.79% | -4.41 | 2.61 | 59.15% |
| Q4 2023 Q2Q % growth | -2.40 -321.05% | -4.12 | 1.72 | 41.76% |
| Q3 2023 Q2Q % growth | -0.44 15.38% | -0.29 | -0.15 | -52.25% |
| Q2 2023 Q2Q % growth | -0.37 42.19% | -0.08 | -0.29 | -385.28% |
| Q1 2023 Q2Q % growth | -0.57 16.18% | -0.56 | -0.01 | -2.54% |
| Q4 2022 Q2Q % growth | -0.57 12.31% | -0.50 | -0.07 | -13.47% |
| Q3 2022 Q2Q % growth | -0.52 30.67% | -0.56 | 0.04 | 7.31% |
| Q2 2022 Q2Q % growth | -0.64 13.51% | -0.58 | -0.06 | -9.60% |
| Q1 2022 Q2Q % growth | -0.68 -4.62% | -0.60 | -0.08 | -12.57% |
| Q4 2021 Q2Q % growth | -0.65 10.96% | -0.75 | 0.10 | 13.88% |
| Q3 2021 Q2Q % growth | -0.75 25.74% | -0.77 | 0.02 | 2.97% |
| Q2 2021 Q2Q % growth | -0.74 7.50% | -0.68 | -0.06 | -8.12% |
| Q1 2021 Q2Q % growth | -0.65 15.58% | -0.78 | 0.13 | 16.97% |
| Q4 2020 Q2Q % growth | -0.73 -1.39% | -0.92 | 0.19 | 20.48% |
| Q3 2020 Q2Q % growth | -1.01 -77.19% | -0.82 | -0.19 | -23.20% |
| Q2 2020 Q2Q % growth | -0.80 -19.40% | -0.78 | -0.02 | -3.05% |
| Q1 2020 Q2Q % growth | -0.77 -6.94% | -0.68 | -0.09 | -13.01% |
| Q4 2019 Q2Q % growth | -0.72 | -0.61 | -0.11 | -18.84% |
| Q3 2019 Q2Q % growth | -0.57 | -0.60 | 0.03 | 4.89% |
| Q2 2019 Q2Q % growth | -0.67 | -0.78 | 0.11 | 13.57% |
| Q1 2019 Q2Q % growth | -0.72 | -0.73 | 0.01 | 1.37% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0.17% | 13.89% | 0.62% | 10.7% |
| Revenue | N/A | N/A | N/A | N/A |